Enzyme Therapy for Patients with Celiac Disease - An Update
Journal: International Journal of Celiac Disease (Vol.9, No. 1)Publication Date: 2021-03-01
Authors : Hugh J. Cornell Teodor Stelmasiak; Aaron Lerner;
Page : 28-34
Keywords : celiac disease; enzyme therapy; caricain; gluten-free diet; gluten intolerance; dermatitis herpetiformis;
Abstract
Enzyme therapy as a management tool for patients with celiac disease (CD) or gluten intolerance is gaining acceptance around the world. Gluten has multiple side effects and limitations of a gluten-free diet (GFD) in management of CD are evident and mainly related to the presence of hidden gluten or cross-contamination of meals in restaurants. The present paper discusses enzyme therapy with caricain, namely Gluteguard, in light of various approaches searching for a treatment or an effective management of CD. Regular users of the supplement Gluteguard report a high level of satisfaction with the product. This indicates that enzyme therapy based on caricain has its place as a safeguard when the gluten-free meals are prepared outside the control of the patients.
Other Latest Articles
- For Patients wih Celiac Disease: Pay Attention to Polluted Seafood
- Glten-free Foods and Their Contribution to Total Diet in Patients with Celiac Disease
- In a Time of Pandemic: Predictors for Post-transplant Respiratory Complications
- Th COVID-19 Vaccination Debate: Is there is a Link between COVID-19 and Celiac Disease?
- The COVID-19 Vaccination Debate: CoV-2 in Celiac Disease: A Pathogen or just along for the Ride?
Last modified: 2021-05-10 04:04:00